Editorial: Insights in Rheumatology: 2021.
作者信息
Fonseca João E, Duarte-Monteiro Ana Margarida
机构信息
Rheumatology Department, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal.
Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
出版信息
Front Med (Lausanne). 2022 Jul 22;9:971777. doi: 10.3389/fmed.2022.971777. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Insights in Rheumatology: 2021.社论：风湿病学见解：2021年。
Front Med (Lausanne). 2022 Jul 22;9:971777. doi: 10.3389/fmed.2022.971777. eCollection 2022.
2
Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPK-dependent signalling pathways.白细胞介素-17通过磷脂酰肌醇3激酶、核因子κB和p38丝裂原活化蛋白激酶依赖性信号通路上调类风湿关节炎滑膜成纤维细胞中白细胞介素-23p19的表达。
Rheumatology (Oxford). 2007 Jan;46(1):57-64. doi: 10.1093/rheumatology/kel159. Epub 2006 Jun 12.
3
Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts.白细胞介素-22通过诱导人滑膜成纤维细胞中的核因子κB受体活化因子配体促进类风湿关节炎中的破骨细胞生成。
Arthritis Rheum. 2012 Apr;64(4):1015-23. doi: 10.1002/art.33446. Epub 2011 Oct 27.
4
Retinoblastoma suppression of matrix metalloproteinase 1, but not interleukin-6, through a p38-dependent pathway in rheumatoid arthritis synovial fibroblasts.视网膜母细胞瘤通过类风湿性关节炎滑膜成纤维细胞中依赖p38的途径抑制基质金属蛋白酶1，但不抑制白细胞介素6。
Arthritis Rheum. 2004 Jan;50(1):78-87. doi: 10.1002/art.11482.
5
An investigation of cell proliferation and soluble mediators induced by interleukin 1beta in human synovial fibroblasts: comparative response in osteoarthritis and rheumatoid arthritis.白细胞介素1β诱导人滑膜成纤维细胞的细胞增殖及可溶性介质的研究：骨关节炎与类风湿关节炎的比较反应
Inflamm Res. 2001 Feb;50(2):65-72. doi: 10.1007/s000110050726.
6
Characterization of interleukin-7 and interleukin-7 receptor in the pathogenesis of rheumatoid arthritis.类风湿关节炎发病机制中白细胞介素-7及白细胞介素-7受体的特征
Arthritis Rheum. 2011 Oct;63(10):2884-93. doi: 10.1002/art.30493.
7
A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways.白细胞介素-18在通过核因子κB和磷脂酰肌醇（PI）3激酶依赖性信号转导途径诱导黏附分子中的新作用。
J Biol Chem. 2001 Oct 5;276(40):37069-75. doi: 10.1074/jbc.M103574200. Epub 2001 Jul 27.
8
Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis.白细胞介素-29调节类风湿关节炎滑膜炎症中促炎细胞因子的产生。
Arthritis Res Ther. 2012 Oct 19;14(5):R228. doi: 10.1186/ar4067.
9
Elevated Levels of Soluble ST2 were Associated with Rheumatoid Arthritis Disease Activity and Ameliorated Inflammation in Synovial Fibroblasts.可溶性 ST2 水平升高与类风湿关节炎疾病活动相关，并改善滑膜成纤维细胞的炎症。
Chin Med J (Engl). 2018 Feb 5;131(3):316-322. doi: 10.4103/0366-6999.223847.
10
IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts.白细胞介素-6和基质金属蛋白酶-1在滑膜成纤维细胞中受细胞周期蛋白依赖性激酶抑制剂p21调控。
J Immunol. 2003 Jan 15;170(2):838-45. doi: 10.4049/jimmunol.170.2.838.
本文引用的文献
1
Etiology and Risk Factors for Rheumatoid Arthritis: A State-of-the-Art Review.类风湿关节炎的病因及危险因素：最新综述
Front Med (Lausanne). 2021 Nov 26;8:689698. doi: 10.3389/fmed.2021.689698. eCollection 2021.
2
JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis.JAK抑制剂与类风湿关节炎中B细胞免疫反应的调节
Front Med (Lausanne). 2021 Feb 5;7:607725. doi: 10.3389/fmed.2020.607725. eCollection 2020.
3
Major Challenges in Rheumatology: Will We Ever Treat Smarter, Instead of Just Harder?风湿病学的主要挑战：我们能否更明智地治疗，而非仅仅加大治疗力度？
Front Med (Lausanne). 2019 Jun 26;6:144. doi: 10.3389/fmed.2019.00144. eCollection 2019.
4
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab.贝利尤单抗治疗的难治性系统性红斑狼疮患者中BLyS水平变化与B和T细胞亚群组成之间的关联
Front Pharmacol. 2019 Apr 25;10:433. doi: 10.3389/fphar.2019.00433. eCollection 2019.
5
B cell alterations during BAFF inhibition with belimumab in SLE.在 SLE 中使用贝利尤单抗抑制 BAFF 时 B 细胞的改变。
EBioMedicine. 2019 Feb;40:517-527. doi: 10.1016/j.ebiom.2018.12.035. Epub 2018 Dec 26.
6
Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study.长期贝利尤单抗治疗对系统性红斑狼疮患者B细胞的影响：一项II期双盲、安慰剂对照、剂量范围研究的扩展
Arthritis Rheum. 2010 Jan;62(1):201-10. doi: 10.1002/art.27189.
Zotero 插件